HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension.

Abstract
Arterial hypertension vascular injury results in serious complications, such as left-ventricular hypertrophy and myocardial failure, ischemic heart disease and cerebral stroke. Currently, it is well known that inflammatory factors play a significant role in the mechanisms that trigger and enhance the remodeling of the vascular wall. A number of data suggest an important role of adhesion molecules and chemokines in this processes. The aim of this study was measuring the plasma levels of soluble Intercellular Adhesion Molecule 1 (sICAM-1) and Monocyte Chemoattractant Peptide1 (MCP-1) in patients with essential hypertension vs. healthy volunteers by ELISA method (R&D kits). sICAM-1 and MCP-1 levels were significantly higher in hypertensive patients compared to controls (sICAM-1: 279.2 +/- 8.8 ng/ml vs. 224.4 +/- 1.8 ng/ml; p < 0.001; MCP-1: 142.2 +/- 7 pg/ml vs. 95.4 +/- 36 pg/ml; p < 0.0001. Our results indicate that arterial hypertension alone (without inflammation, lipid and carbohydrate disorders) may increase the expression of these cytokines and contribute to the progression of endothelial injury.
AuthorsAndrzej Madej, Bogusław Okopień, Jan Kowalski, Maciej Haberka, Zbigniew S Herman
JournalPharmacological reports : PR (Pharmacol Rep) 2005 Nov-Dec Vol. 57 Issue 6 Pg. 878-81 ISSN: 1734-1140 [Print] Switzerland
PMID16382212 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • CCL2 protein, human
  • Chemokine CCL2
  • Lipids
  • Intercellular Adhesion Molecule-1
Topics
  • Adult
  • Chemokine CCL2 (blood)
  • Female
  • Humans
  • Hypertension (blood)
  • Intercellular Adhesion Molecule-1 (blood)
  • Lipids (blood)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: